Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Left Atrial Ablation After Percutaneous Left Atrial Appendage Occlusion in High-Bleeding-Risk Patients With Atrial Fibrillation: PROCEED-AF Ablation Registry

NCT07580937 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT07580937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07580937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Left Atrial Ablation After Percutaneous Left Atrial Appendage Occlusion in High-Bleeding-Risk Patients With Atrial Fibrillation: PROCEED-AF Ablation Registry
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Completed
Start date
March 8, 2022
Completion date
March 30, 2026
Enrollment
198 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

atrial arrhythmia, atrial fibrillation